Form 4: Vivani Medical Director Boosts Stake, Corrects Past Filing

Vivani Medical Director Aaron Mendelsohn reported an open market purchase of 20,000 shares and disclosed a previously unfiled gift of 20,000 shares.

Summary

• Vivani Medical, Inc. Director Aaron Mendelsohn reported changes in his beneficial ownership.
• On July 8, 2024, Mendelsohn gifted 20,000 shares of common stock to a non-affiliated entity. This transaction was inadvertently not filed previously.
• On December 29, 2025, Mendelsohn purchased 20,000 shares of common stock on the open market at a weighted average price of $1.23 per share.
• Following these transactions, Mendelsohn directly owns 188,170 shares of common stock.
• His total beneficial ownership, including indirect holdings through trusts for grandchildren and MFE, LLC, amounts to 1,086,487 shares.
• Mendelsohn disclaims pecuniary interest in 149,478 shares held by MFE, LLC, which are beneficially owned by other members.

Sentiment

Score: 7

Explanation: The open market purchase by a director indicates confidence in the company's valuation and future prospects. The delayed reporting of a past gift is an administrative issue but does not significantly detract from the positive signal of the purchase.

Positives

• A director, Aaron Mendelsohn, purchased 20,000 shares of Vivani Medical, Inc. common stock on the open market at a weighted average price of $1.23 per share, indicating confidence in the company's future.
• The purchase increases his direct beneficial ownership to 188,170 shares.

Negatives

• The filing indicates a delay in reporting a gift of 20,000 shares made on July 8, 2024, which was "inadvertently not previously filed." While corrected, this points to a past administrative oversight.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing reports an insider transaction, which is specific to the individual director and the company's stock. It does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The director's purchase could be seen as a positive signal, potentially increasing investor confidence. The increase in direct ownership aligns the director's interests more closely with shareholders.
• Regulatory Authorities: The delayed filing of the gift transaction, though now corrected, highlights the importance of timely and accurate disclosure under Section 16(a) of the Securities Exchange Act of 1934.

Key Dates

Recommendation

The open market purchase of shares by a director, Aaron Mendelsohn, at a price of $1.23 per share, signals strong insider confidence in Vivani Medical, Inc.'s future performance and valuation. This action suggests that management believes the stock is undervalued or poised for growth, making it a compelling signal for potential investors.

Keywords

Vivani Medical, VANI, Insider Trading, Form 4, Director Stock Purchase, Stock Ownership, Beneficial Ownership, Equity Transaction, Aaron Mendelsohn